Myasthenia Gravis clinical trials at UC Cancer
2 research studies open to eligible people
Showing trials for
A Study To Evaluate Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Generalized Myasthenia Gravis
open to eligible people ages 12 years and up
This study will evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of satralizumab compared with placebo in participants with generalized myasthenia gravis (gMG).
at UC Irvine
Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)
open to eligible people ages 18 years and up
This is a Phase IIb study to evaluate the safety and preliminary efficacy of Descartes-08 CAR T-cells in patients with Generalized Myasthenia Gravis
at UC Irvine
Our lead scientists for Myasthenia Gravis research studies include Tahseen Mozaffar, MD.